These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 31117160

  • 1. Reactivation of hepatitis B virus infection following rituximab treatment in HBsAg-negative, HBcAb-positive rheumatoid arthritis patients: A long-term, real-world observation.
    Chen YM, Chen HH, Huang WN, Chen YH, Hsieh TY, Yang SS, Lan JL, Chen DY.
    Int J Rheum Dis; 2019 Jun; 22(6):1145-1151. PubMed ID: 31117160
    [Abstract] [Full Text] [Related]

  • 2. Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.
    Lan JL, Chen YM, Hsieh TY, Chen YH, Hsieh CW, Chen DY, Yang SS.
    Ann Rheum Dis; 2011 Oct; 70(10):1719-25. PubMed ID: 21719446
    [Abstract] [Full Text] [Related]

  • 3. Incidence and clinical characteristics of hepatitis B virus reactivation in HBsAg-negative/HBcAb-positive patients receiving rituximab for rheumatoid arthritis.
    Tien YC, Yen HH, Chiu YM.
    Clin Exp Rheumatol; 2017 Oct; 35(5):831-836. PubMed ID: 28375829
    [Abstract] [Full Text] [Related]

  • 4. Changes in hepatitis B virus surface antibody titer and risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients undergoing biologic therapy for rheumatic diseases: a prospective cohort study.
    Tien YC, Yen HH, Li CF, Liu MP, Hsue YT, Hung MH, Chiu YM.
    Arthritis Res Ther; 2018 Nov 01; 20(1):246. PubMed ID: 30382902
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of hepatitis B virus in clinical trials of baricitinib in rheumatoid arthritis.
    Harigai M, Winthrop K, Takeuchi T, Hsieh TY, Chen YM, Smolen JS, Burmester G, Walls C, Wu WS, Dickson C, Liao R, Genovese MC.
    RMD Open; 2020 Feb 01; 6(1):. PubMed ID: 32098857
    [Abstract] [Full Text] [Related]

  • 6. Moderate Risk of Hepatitis B Virus Reactivation in HBsAg-/HBcAb+ Carriers Receiving Rituximab for Rheumatoid Arthritis.
    Kuo MH, Tseng CW, Lee CH, Tung CH, Tseng KC, Lai NS.
    Sci Rep; 2020 Feb 12; 10(1):2456. PubMed ID: 32051458
    [Abstract] [Full Text] [Related]

  • 7. Hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients receiving rituximab for lymphoma: a meta-analysis.
    Mozessohn L, Chan KK, Feld JJ, Hicks LK.
    J Viral Hepat; 2015 Oct 12; 22(10):842-9. PubMed ID: 25765930
    [Abstract] [Full Text] [Related]

  • 8. Hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients receiving immunosuppressive therapy for glomerulonephritis: a retrospective analysis.
    Fang J, Li W, Peng X, Tan Z, Tan M, Zhang C, Wang W, Xu Z, Zhou G.
    Int Urol Nephrol; 2017 Mar 12; 49(3):475-482. PubMed ID: 28032257
    [Abstract] [Full Text] [Related]

  • 9. HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAb.
    Sarrecchia C, Cappelli A, Aiello P.
    J Infect Chemother; 2005 Aug 12; 11(4):189-91. PubMed ID: 16133710
    [Abstract] [Full Text] [Related]

  • 10. Safety of TNF-blocking agents in rheumatic patients with serology suggesting past hepatitis B state: results from a cohort of 21 patients.
    Charpin C, Guis S, Colson P, Borentain P, Mattéi JP, Alcaraz P, Balandraud N, Thomachot B, Roudier J, Gérolami R.
    Arthritis Res Ther; 2009 Aug 12; 11(6):R179. PubMed ID: 19941642
    [Abstract] [Full Text] [Related]

  • 11. Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B-cell lymphoma patients who are HBsAg-negative/ HBcAb-positive: a multicenter retrospective study.
    Ji D, Cao J, Hong X, Li J, Wang J, Chen F, Wang C, Zou S.
    Eur J Haematol; 2010 Sep 12; 85(3):243-50. PubMed ID: 20491883
    [Abstract] [Full Text] [Related]

  • 12. Impact of Hepatitis B Surface and Core Antibody Levels on Hepatitis B Virus Reactivation.
    Ohkubo M, Seo E, Doki K, Suzuki Y, Sekine I, Homma M.
    Biol Pharm Bull; 2024 Sep 12; 47(5):941-945. PubMed ID: 38735754
    [Abstract] [Full Text] [Related]

  • 13. Safety of Tocilizumab in Rheumatoid Arthritis Patients with Resolved Hepatitis B Virus Infection: Data from Real-World Experience.
    Ahn SS, Jung SM, Song JJ, Park YB, Park JY, Lee SW.
    Yonsei Med J; 2018 May 12; 59(3):452-456. PubMed ID: 29611409
    [Abstract] [Full Text] [Related]

  • 14. Improving testing for hepatitis B before treatment with rituximab.
    Dyson JK, Jopson L, Ng S, Lowery M, Harwood J, Waugh S, Valappil M, McPherson S.
    Eur J Gastroenterol Hepatol; 2016 Oct 12; 28(10):1172-8. PubMed ID: 27388147
    [Abstract] [Full Text] [Related]

  • 15. HBV reactivation in HBsAg-/HBcAb+ rheumatoid arthritis patients receiving biologic/targeted synthetic DMARDs.
    Kuo MH, Tseng CW, Ko PH, Wang ST, Lu MC, Tung CH, Tseng KC, Huang KY, Lee CH, Lai NS.
    Liver Int; 2024 Feb 12; 44(2):497-507. PubMed ID: 38010984
    [Abstract] [Full Text] [Related]

  • 16. Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg-negative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancer.
    Borentain P, Colson P, Coso D, Bories E, Charbonnier A, Stoppa AM, Auran T, Loundou A, Motte A, Ressiot E, Norguet E, Chabannon C, Bouabdallah R, Tamalet C, Gérolami R.
    J Viral Hepat; 2010 Nov 12; 17(11):807-15. PubMed ID: 20002298
    [Abstract] [Full Text] [Related]

  • 17. Prospective study of HBV reactivation risk in rheumatoid arthritis patients who received conventional disease-modifying antirheumatic drugs.
    Tan J, Zhou J, Zhao P, Wei J.
    Clin Rheumatol; 2012 Aug 12; 31(8):1169-75. PubMed ID: 22544263
    [Abstract] [Full Text] [Related]

  • 18. Reactivation of hepatitis B virus infection in patients with rheumatoid arthritis receiving tofacitinib.
    Wang ST, Tseng CW, Hsu CW, Tung CH, Huang KY, Lu MC, Lai NS.
    Int J Rheum Dis; 2021 Nov 12; 24(11):1362-1369. PubMed ID: 34506078
    [Abstract] [Full Text] [Related]

  • 19. Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc-positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian Study.
    Varisco V, Viganò M, Batticciotto A, Lampertico P, Marchesoni A, Gibertini P, Pellerito R, Rovera G, Caporali R, Todoerti M, Covelli M, Notarnicola A, Atzeni F, Sarzi-Puttini P.
    J Rheumatol; 2016 May 12; 43(5):869-74. PubMed ID: 26879359
    [Abstract] [Full Text] [Related]

  • 20. Hepatitis B virus reactivation in patients with resolved hepatitis B virus infection receiving chemotherapy or immunosuppressive therapy.
    Su YC, Lin PC, Yu HC, Wu CC.
    Eur J Gastroenterol Hepatol; 2018 Aug 12; 30(8):925-929. PubMed ID: 29621049
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.